BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11993063)

  • 1. From proposal to patient: how CMS makes coverage decisions.
    Turnbull GB
    Ostomy Wound Manage; 2002 Apr; 48(4):8-10, 82. PubMed ID: 11993063
    [No Abstract]   [Full Text] [Related]  

  • 2. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential legal barriers to increasing CMS/FDA collaboration: the law of trade secrets and related considerations.
    Wang SS; Smith JJ
    Food Drug Law J; 2003; 58(4):613-27. PubMed ID: 15027453
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the Office of Health Technology Assessment in Medicare coverage decisions.
    Marshall JE; Carter ED
    J Health Care Technol; 1986; 3(2):75-8. PubMed ID: 10301219
    [No Abstract]   [Full Text] [Related]  

  • 5. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.
    Dhruva SS; Redberg RF
    Arch Intern Med; 2008 Jan; 168(2):136-40. PubMed ID: 18227358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare coverage of new technologies: initial responses.
    Schatz GB
    Healthspan; 1989 May; 6(5):3-7. PubMed ID: 10313103
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives. CMS and Wall Street report...
    Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066
    [No Abstract]   [Full Text] [Related]  

  • 8. Miracles in the making.
    Wagner L
    Provider; 2003 Mar; 29(3):22-6, 28, 31-6. PubMed ID: 12666330
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffusion of new technologies. Can Medicare payment decisions be made faster and more efficiently?
    VanAntwerp M
    J Health Care Technol; 1985; 2(2):97-103. PubMed ID: 10300492
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare coverage of technology.
    Schatz GB
    Healthspan; 1987 Jul; 4(7):9-13. PubMed ID: 10313725
    [No Abstract]   [Full Text] [Related]  

  • 11. CMS policy on clinical trials coverage: questions remain.
    Fulton A
    AHIP Cover; 2007; 48(6):10, 66. PubMed ID: 18183873
    [No Abstract]   [Full Text] [Related]  

  • 12. Considering changes to CMS's national coverage decision process: applying lessons learned from FDA as a regulator of access to healthcare technology.
    Zalesky CD
    Food Drug Law J; 2002; 57(1):73-93. PubMed ID: 12118482
    [No Abstract]   [Full Text] [Related]  

  • 13. The Federal regulation of medical devices.
    Kessler DA; Pape SM; Sundwall DN
    N Engl J Med; 1987 Aug; 317(6):357-66. PubMed ID: 3299097
    [No Abstract]   [Full Text] [Related]  

  • 14. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
    Smith JJ; Henderson JA
    J Am Coll Radiol; 2008 Mar; 5(3):189-92. PubMed ID: 18312966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCFA's role in Medicare coverage decisions.
    Roper WL
    J Health Care Technol; 1986; 3(2):79-81. PubMed ID: 10301220
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacometrics at FDA: evolution and impact on decisions.
    Powell JR; Gobburu JV
    Clin Pharmacol Ther; 2007 Jul; 82(1):97-102. PubMed ID: 17538553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare's national coverage decisions, 1999-2003: quality of evidence and review times.
    Neumann PJ; Divi N; Beinfeld MT; Levine BS; Keenan PS; Halpern EF; Gazelle GS
    Health Aff (Millwood); 2005; 24(1):243-54. PubMed ID: 15647237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMS details coverage of electrical stimulation and electromagnetic therapy for wound treatment in home health setting.
    Home Healthc Nurse; 2004 Oct; 22(10):676. PubMed ID: 15486504
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical device development: from prototype to regulatory approval.
    Kaplan AV; Baim DS; Smith JJ; Feigal DA; Simons M; Jefferys D; Fogarty TJ; Kuntz RE; Leon MB
    Circulation; 2004 Jun; 109(25):3068-72. PubMed ID: 15226221
    [No Abstract]   [Full Text] [Related]  

  • 20. How changes in the Medicare coverage process have facilitated the spread of new technologies.
    Straube BM
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-314-W5-316. PubMed ID: 15975989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.